Baxter International Inc. Baxter International Inc.

Baxter International Inc.

BAX

शेयरों में रैंक #1657
Baxter International Inc., operating globally via its subsidiaries, is a... Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution. Further expanding its pharmaceutical offerings, Baxter delivers pre-mixed and oncology drug platforms, inhaled anesthetic agents, critical care products, and pharmacy compounding services. Nutritional support is provided through its parenteral nutrition therapies and associated products. For surgical procedures, the company develops biological products and medical devices vital for achieving hemostasis, tissue sealing, and preventing adhesions. Additionally, Baxter supplies continuous renal replacement therapies (CRRT) and other organ support solutions, primarily tailored for intensive care units. Beyond direct medical supplies, Baxter provides sophisticated connected care solutions, integrating devices, software, communication systems, and other advanced technologies. This includes a range of patient monitoring and diagnostic technologies designed to aid in the diagnosis, treatment, and management of numerous illnesses and conditions, spanning respiratory therapy, cardiology, vision screening, and physical assessment. The surgical suite benefits from its specialized video technologies, operating tables, lights, pendants, precision positioning tools, and various ancillary accessories. The company also offers contracted services to a multitude of pharmaceutical and biopharmaceutical companies. Baxter's products are utilized across diverse healthcare environments, including hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and for home-based patients under medical supervision. Operating in approximately 100 countries, Baxter distributes its extensive product line through a direct sales force, independent distributors, drug wholesalers, and specialty pharmacies or other alternative site providers. The company also holds a collaborative agreement with Celerity Pharmaceutical, LLC, focused on developing generic injectable pre-mixed medications for acute care and oncolytic molecules. Established in 1931, Baxter International Inc. is headquartered in Deerfield, Illinois.
शेयर मूल्य
$25.08
मार्केट कैप
$12.96B
बदलाव (1 दिन)
-0.83%
बदलाव (1 वर्ष)
8.60%
देश
US
व्यापार Baxter International Inc. (BAX)

श्रेणी

Healthcare
Baxter International Inc. (BAX) के लिए ऑपरेटिंग मार्जिन
October 2026 को ऑपरेटिंग मार्जिन TTM: -2.39%
Baxter International Inc. की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी का वर्तमान ऑपरेटिंग मार्जिन (TTM) -2.39% है। 2023 के अंत में, कंपनी का ऑपरेटिंग मार्जिन 6.82% था।
Baxter International Inc. के लिए 2000 से 2026 तक ऑपरेटिंग मार्जिन का इतिहास
हर वर्ष के अंत में ऑपरेटिंग मार्जिन
वर्ष ऑपरेटिंग मार्जिन परिवर्तन
2026 (TTM) -2.39% -1,938.46%
2024 0.13% -98.09%
2023 6.82% -124.11%
2022 -28.29% -354.64%
2021 11.11% -19.73%
2020 13.84% -11.28%
2019 15.60% 9.32%
2018 14.27% 17.26%
2017 12.17% 66.03%
2016 7.33% 62.89%
2015 4.50% -26.47%
2014 6.12% 16.13%
2013 5.27% -73.96%
2012 20.24% -4.53%
2011 21.20% 27.48%
2010 16.63% -27.38%
2009 22.90% 10.31%
2008 20.76% 7.84%
2007 19.25% 8.51%
2006 17.74% 6.61%
2005 16.64% 76.83%
2004 9.41% -33.40%
2003 14.13% -25.16%
2002 18.88% 13.53%
2001 16.63% 7.71%
2000 15.44% 0.00%
समान कंपनियों या प्रतिस्पर्धियों के लिए ऑपरेटिंग मार्जिन
कंपनी ऑपरेटिंग मार्जिन ऑपरेटिंग मार्जिन में अंतर देश
31.28% -113.09%
US
12.36% -105.17%
FR
0.00% -
JP
9.83% -104.11%
US
0.00% -
CH
कंपनी का ऑपरेटिंग मार्जिन क्या होता है?
ऑपरेटिंग मार्जिन किसी कंपनी की लाभप्रदता का मूल्यांकन करने के लिए एक प्रमुख संकेतक है। उच्च ऑपरेटिंग मार्जिनs आम तौर पर बेहतर माने जाते हैं क्योंकि यह दर्शाता है कि कंपनी अपने उत्पादों या सेवाओं को उनकी उत्पादन लागत से कहीं अधिक मूल्य पर बेचने में सक्षम है। इसे कंपनी की कमाई को उसके राजस्व से विभाजित करके गणना किया जाता है।